Sionna cuts nearly half of staff as it lines up second attempt at cystic fibrosis
Sionna Therapeutics announced it was laying off 46% of its staff as it seeks a way forward following an unexpected trial failure in cystic fibrosis last month.
Sionna Therapeutics
Sionna Therapeutics is a biopharmaceutical company.
Company Info
Recent News
Sionna’s cystic fibrosis failure is a windfall for Vertex’s blockbuster franchise
Sionna’s cystic fibrosis failure is a windfall for Vertex’s blockbuster franchise
Sionna’s cystic fibrosis flop a ‘significant’ boost for Vertex
Sionna’s cystic fibrosis flop a ‘significant’ boost for Vertex